Abstract:e13026 Background: Aromatase, encoded by CYP19A1 gene, is a rate-limiting enzyme in the conversion of androgens into estrogens. Given the critical role of CYP19A1gene in estrogen synthesis, the potential impact of genetic polymorphisms in CYP19A1 gene on the survival of breast cancer deserves further study. Methods: Rs1008805 polymorphism in CYP19A1 gene were genotyped on 406 Chinese Han women with stage I-II and operable stage III breast cancer. Associations were explored betweenrs1008805 genotypes and disease-free survival (DFS). Results: Totally, there were 200 (49.3%) patients with AA genotype, 169 (41.6%) with AG variant, and 37 (9.1%) carrying GG variant. No significant differences were found in DFS or 5-year survival rate among the whole population with these three genotypes. However, in postmenopausal women, rs1008805 genotypes were significantly related to worse DFS and 5-years DFS rate (AA versus AG versus GG: 63.1 months versus 54.3 months versus 13.7 months; 48.6% versus 46.0% versus 14.3%; P = 0.015). In addition, women with GG variant had a poorer DFS, 5-years DFS rate when compared with those carrying AG or AA genotype (GG versus AG or AA: 13.7 months versus 56.3 months; 0% versus 52.1%; HR, 2.462; 95 % CI, 1.310-4.628; P = 0.004). Being adjusted by patients features in multivariate analyses, GG genotype remained an independent prognostic factor for DFS (HR, 2.706; 95 % CI, 1.393-5.257; P = 0.003). Besides, women with the homozygous minor allele had a marginally improved DFS, 5-years DFS rate when compared with those carrying the common allele (GG versus AG or AA: 87.0 months versus 48.7 months; 60.3% versus 42.7 %; HR, 0.544; 95% CI, 0.295-1.003; P= 0.051). However, there was no relationship between GG genotype and DFS or 5-year DFS when adjusted by patients features in multivariate analyses. Conclusions: The present study demonstrated that homozygous minor allele of rs1008805 SNP in CYP19A1 gene was significantly related to a worse DFS in postmenopausal women with early breast cancer. This founding is novel, if confirmed, CYP19A1 rs1008805 genotypes may turned to be a prognostic biomarker for early breast cancer.

A Genetic Polymorphism (Rs17251221) In The Calcium-Sensing Receptor Is Associated With Ovarian Cancer Susceptibility

A Genetic Polymorphism (rs17251221) in the Calcium-Sensing Receptor is Associated with Breast Cancer Susceptibility and Prognosis

Microrna Processing and Binding Site Polymorphisms Are Not Replicated in the Ovarian Cancer Association Consortium

A Genome-Wide Association Study Identifies a New Ovarian Cancer Susceptibility Locus on 9P22.2.

The Association of CASC16 Variants with Breast Cancer Risk in a Northwest Chinese Female Population

A Single Nucleotide Polymorphism in XRCC4 Gene is Associated with Reduced Colorectal Cancer Susceptibility in Female

A Polymorphism at Mirna-122-binding Site in the IL-1α 3′UTR is Associated with Risk of Epithelial Ovarian Cancer

Analysis of the association between the XRCC2 rs3218536 polymorphism and ovarian cancer risk

Association Between a Novel Polymorphism (rs2046210) of the 6q25.1 Locus and Breast Cancer Risk

Genetic polymorphisms in AURKA, BRCA1, CCNE1 and CDK2 are associated with ovarian cancer susceptibility among Chinese Han women

CXCL12 Rs266085 and TNF-α Rs1799724 Polymorphisms and Susceptibility to Cervical Cancer in a Chinese Population.

Calcium-sensing receptor gene polymorphism (rs7652589) is associated with calcium nephrolithiasis in the population of Yi nationality in Southwestern China

Association of oncostatin M receptor polymorphisms with clinical recurrence of ovarian cancer in the Chinese Han population

CASC15 Polymorphisms Are Correlated with Cervical Cancer Susceptibility in Chinese Women

Association between the CASC16 rs4784227 polymorphism and breast cancer risk and prognosis in a northeast Chinese Han population

Single Nucleotide Polymorphisms of Follicle-Stimulating Hormone Receptor Are Associated with Ovarian Cancer Susceptibility.

CDH1 Gene Rs1801552 C/T Polymorphism Increases Susceptibility to Esophageal Squamous Cell Carcinoma but Not to Gastric Cardiac Adenocarcinoma.

Association of CXCL12 and TNF-α Gene Polymorphisms and Susceptibility to Cervical Cancer.

Associations of CXCL1 Gene 5’UTR Variations with Ovarian Cancer

Abstract LB147: Fine-scale mapping of chromosome 9q22.33 identifies candidate causal variant in ovarian cancer

Association of Rs1008805 Polymorphism in the Cyp19a1 Gene with the Prognosis of Early Breast Cancer.